Experimental rats were divided as follows: diabetic control (DC, N=9), captopril-treating group (DT, N=12) and normal controls (NC).
Results: moderate hyperglycemia were maintained in diabetic groups throughout the experiment period. There was no difference of blood glucose levels before and after the treatment, HbA1c levels was similar between DT and DC at end of 6th month of the experiment. The increased urinary protein (IUP) in DC and DT groups was significantly higher than that in NC. IUP in DS was significantly lower than that in DC. MGV in DC and DT groups was bigger than that in NC (p<0.05). MGV in DT was smaller than in DC, but the difference was not significant. Creatinine clearance rate (CCr) in DC and DT was significantly increased; CCr in DC was higher than that in DT.
Histology: light microscope showed no significant morphological changes in DC and DT. However, enlargement of mesangial cells and matrix, thickening of glomerular basement membrance were observed in both DC and DT under electric microscope. The glomerular lesion in DC was prominent as compared wiht that in DT. NC showed no glomerular morphological lesions.
The results mentioned above reveal that the disorder of glucose metabolism could cause renal function and structure injury and that administration of captopril in the early stage of experimental diabetic may delay the formation of the diabetic glomerulopathy.
Immediately after right nephrectomy, 18 mongrel dogs were randomly divided into 3 groups. Group A (n=6) served as saline treated controls. Group B (n=6) was treated with postischemic intravenous ATP-MgCl230μmol/kg in saline 6ml/kg and group C (n=6) with inosine 150mg/kg. Acute renal failure (ARF) was induced by occluding the left renal artery for 1 hour under general anaesthesia. Renal function changes has been observeb for 5 hours